ADO : Lithium & Rapid Covid tests?

ASX:ADO ANTEOTECH LTD

Anteotech Ltd have demonstrated remarkable gainst during 2020, even more so in 2021. The energy division aims to increase lithium battery capacity using nanotechnology silicon composite. The Life Science division has made progress on flagship COVID19 test kits with several other products in market.

Recent ADO ASX announcements have focussed on their Covid rapid test.

Head of Diagnostics & Life Science Charlie Huang did long format interview with InvestorStream in October 2020.

• ADO do not have internal manufacturing capacity, internal lab manufacturing capacity has focussed on producing for early stage testing.
• Consultants engaged for the TGA approval process.
• Significant difference between Au rapid test policy and Eu, USA policy.
• Sepsis rapid test has value, Sepsis is lethal and a significant issue.

26/02/2021 12:02 pm AEDT ASX App 4D and Interim Financial Report

Understand the difference between Net Loss, Sales Revenue and Total Sales Revenue.